GRP78 blockade overcomes intrinsic resistance to UBA1 inhibitor TAK-243 in glioblastoma
Cited by 22
Related Papers
Hypoxia-responsive ionizable liposome delivery siRNA for glioma therapy
|International Journal of Nanomedicine|2017|95
CRM1/XPO1 is associated with clinical outcome in glioma and represents a therapeutic target by perturbing multiple core pathways
|Journal of Hematology & Oncology|2016|80
<p>Combined Delivery of Temozolomide and siPLK1 Using Targeted Nanoparticles to Enhance Temozolomide Sensitivity in Glioma</p>
|International Journal of Nanomedicine|2020|56